Aug 29, 2024 06:14AM
Aug 28, 2024 08:59PM
Aug 20, 2024 07:45AM
Aug 20, 2024 07:45AM
May 17, 2024 08:10AM
May 17, 2024 08:09AM
Mar 1, 2024 04:09PM Form S-3 GeoVax Labs, Inc.
Apr 17, 2023 09:04AM
Jul 28, 2022 09:02AM
May 25, 2022 01:48PM
May 25, 2022 01:47PM
Mar 22, 2022 09:01AM
Mar 22, 2022 09:00AM
Mar 22, 2022 09:00AM GeoVax Announces Issuance of Cancer Vaccine Patent
Jan 14, 2022 08:41AM
Jan 14, 2022 08:41AM
Jan 14, 2022 08:41AM
Jan 13, 2022 09:00AM
Jan 13, 2022 09:00AM
Jan 11, 2022 09:00AM
Jan 11, 2022 09:00AM GeoVax Appoints Dr. Kelly McKee as Chief Medical Officer
Jan 11, 2022 09:00AM
Jan 5, 2022 09:00AM
Jan 5, 2022 09:00AM
Jan 4, 2022 09:02AM
Jan 4, 2022 09:00AM
Jan 4, 2022 09:00AM
Dec 15, 2021 09:03AM Geovax Labs (GOVX) Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster
Dec 15, 2021 09:00AM
Dec 15, 2021 09:00AM
Dec 3, 2021 09:02AM
Dec 3, 2021 09:00AM
Dec 3, 2021 09:00AM
Dec 1, 2021 09:00AM
Dec 1, 2021 09:00AM GeoVax Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy Congress
Nov 17, 2021 09:01AM
Nov 17, 2021 09:00AM
Nov 17, 2021 09:00AM
Nov 16, 2021 09:01AM
Nov 16, 2021 09:00AM
Nov 16, 2021 09:00AM
Nov 15, 2021 09:00AM GeoVax Announces Upcoming Presentations at Scientific Conferences
Nov 15, 2021 09:00AM
Nov 11, 2021 04:00PM
Nov 11, 2021 04:00PM
Nov 9, 2021 04:00PM
Nov 9, 2021 04:00PM
Nov 9, 2021 04:00PM
Nov 4, 2021 09:00AM GeoVax to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate Update
Nov 4, 2021 09:00AM

68,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All